Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Meningeal Neoplasms 1Meningeal Carcinomatosis 1Lymphoma 1Leukemia 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 388Specimen Handling 377Magnetic Resonance Spectroscopy 328Radiotherapy 306Biopsy 273Cisplatin 258Carboplatin 255Paclitaxel 235Doxorubicin 226Fluorouracil 200Etoposide 197Vincristine 183Bevacizumab 181Filgrastim 170Gemcitabine 163Leucovorin 149Cytarabine 144aldesleukin 141Taxes 127Docetaxel 122Chemotherapy, Adjuvant 114Oxaliplatin 113fludarabine phosphate 111Methotrexate 108Rituximab 107Radiation 106Bortezomib 105Prednisone 102Irinotecan 100Dexamethasone 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × mafosfamide × Clear all
NCT00031928 2015-04-30

Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors

National Cancer Institute (NCI)

Phase 1 Completed
3,000 enrolled
CNS

Central Nervous System Neoplasms, Meningeal Carcinomatosis

NCT00001251 2013-08-19

Phase I Study of Intrathecal Mafosfamide

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
65 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Meningeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡